Home > News > Tatas to invest around Rs 1,000cr in startups
September 1st, 2008
Tatas to invest around Rs 1,000cr in startups
Abstract:
Tata Industries is planning to invest Rs 800-1,000 crore in biotechnology and nanotechnology. The company has already pum-ped in Rs 125 crore in these segments, Mr Kishor Chau-kar, managing director, said.
"Contract research, drug discovery and herbal medicine are areas that are at the top of our priority list. We are trying to come up with a drug for fighting diabetes and metabolic disorders," Mr Chaukar said. Tata Industries has invested Rs 80 crore in three entities in this segment, of which, Indigene, has operations in Hyderabad.
He said, "We are interested in a bio warfare project that is being developed by a non-resident Indian scientist in association with the US defence department. We think the project has great potential even in the field of medicine and hence have put in Rs 60 crore in the technology." If successful, the company would buy the rights to the technology and launch it in India, Africa and Latin America, he added.
Source:
asianage.com
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Military
Single atoms show their true color July 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||